Larotrectinib
CONNECT1903
Phase 1 small_molecule active
Quick answer
Larotrectinib for High Grade Glioma is a Phase 1 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- High Grade Glioma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active